Results 291 to 300 of about 58,406 (311)

Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia

Biochemical Pharmacology, 2017
John O Miners, Nuy Chau, Andrew Rowland
exaly  

Risk Factors for Neurotoxicity in Newborns With Severe Neonatal Hyperbilirubinemia

Pediatrics, 2011
Aleksandr Aravkin
exaly  

A Comparison of Alternative Risk-Assessment Strategies for Predicting Significant Neonatal Hyperbilirubinemia in Term and Near-Term Infants

Pediatrics, 2008
Ron Keren, Vinod K Bhutani
exaly  

Impact of Universal Bilirubin Screening on Severe Hyperbilirubinemia and Phototherapy Use

Pediatrics, 2009
Thomas B Newman
exaly  

Hyperbilirubinemia

2021
openaire   +1 more source

Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome)

Bailliere's Best Practice and Research in Clinical Gastroenterology, 2010
Christian P Strassburg
exaly  

Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia

Human Molecular Genetics, 2009
Serena Sanna, Sandra Lai, Antonella Mulas   +2 more
exaly  

Hyperbilirubinemia Protects against Aging‐Associated Inflammation and Metabolic Deterioration

Oxidative Medicine and Cellular Longevity, 2016
Jaroslav Zelenka, Aleš Dvořák, Lukáš Alán   +2 more
exaly  

An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation

Journal of Perinatology, 2012
exaly  

Hyperbilirubinemia

2014
openaire   +1 more source